House Call: Bio-Identical Hormone Therapy for Menopause

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

For women who are proper candidates for hormone therapy, clinical evidence has shown that ninety percent of the time, this treatment can eradicate menopausal symptoms, such as severe hot flashes and night sweats, vaginal dryness and help to prevent osteoporosis and osteoporosis-related fractures.

Progesterone and estradiol, a type of estrogen with the highest concentration during a woman’s reproductive years, are the hormones that markedly decrease as women enter menopause.

More: Menopause Statistics

Bio-identical hormone therapies have been developed for both forms of hormones, and are being used to treat women dealing with the symptoms of menopause. The use of bio-identical hormones, which are chemically identical to the hormones produced by the ovaries, has become a popular treatment choice for women.

Many women are aware of the controversy surrounding bio-identical hormone therapy involving custom compounding formulations.  Custom compounding is a process that takes a chemical or drug and manipulates it outside of FDA labeling.  Many people are under the false impression that custom-compounded hormone products are risk-free, ‘all-natural’ and FDA approved; however it is important to understand is that there are no risk-free hormone products, and women should discuss these risks with their doctor before beginning therapy. Although, there are many FDA approved, brand name bio-identical hormone prescription products currently available that do not require custom compounding.

Fortunately, The Women’s Health Network at Cone Health MedCenter High Point has a Certified Menopause Practitioner dedicated to educating women about menopause and providing exceptional treatment for women experiencing the symptoms and body changes often associated with menopause.

Spokesperson Background:

Dr. Deborah Schoenhoff is the medical director at the Women’s Health Network located at Cone Health MedCenter High Point.  As an internal medicine specialist, Dr. Scheonhoff also received advanced training and certification as a Certified Menopause Practitioner from the North American Menopause Society in May 2011. She is a 1989 graduate of University of Cincinnati School of Medicine and completed her residency in Internal Medicine at Moses Cone Hospital in 1994.